Conference Description

October 21, 2006
Park Hyatt Philadelphia
Broad and Walnut Streets
Philadelphia, Pennsylvania 19102
215-893-1234

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 5.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants caring for patients with cardiovascular disease.

Program Summary:
The NACE Cardiovascular Symposium 2006 is a one day program covering recent advances in coronary artery disease risk factor management. The meeting will provide a review of cardiovascular medicine geared to practicing physicians with nationally known faculty presenting evolving issues and challenges relevant to clinical practice. The set of lectures will provide a review of established principles of cardiovascular medicine as well as present new concepts and data in this rapidly advancing field. Key areas for review will include Lipid Management, Acute Coronary Syndrome, Pulmonary Hypertension, Heart Failure and controversies in Drug-Eluting Stents.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. Discuss the favorable benefit to risk ratio of more aggressive statin therapy which translates to reduced myocardial infarction, stroke, and cardiovascular death
2. Discuss the need to increase global utilization of lipid lowering therapy for further reductions in morbidity and mortality than currently achieved
3. Explain the epidemiology, causes and consequences of anemia in heart failure
4. List the effects that erythropoetic agents, in the setting of heart failure, may have on exercise capacity as suggested by pilot studies
5. Identify important aspects in the diagnosis and management of pulmonary hypertension
6. Compare and contrast the drug eluting stents available today in the U.S with a clearer understanding of their indications and safety issues
7. Identify the important aspects in the evaluation and management of acute coronary syndromes

Agenda:

7:30-8:30 am		Registration and Continental Breakfast
8:30-8:45		Welcome Remarks Jose R. Soler, MD
8:45-9:45		New Insights in the Treatment of Dyslipidemia Alexandre Ferreira, MD
9:45-10:45		Diagnosis and Treatment of Anemia in Heart Failure Stuart David Katz, MD
10:45-11:10		Break
11:10-12:10		Diagnosis and Management of Pulmonary Arterial Hypertension Michael A. Mathier, MD, FACC
12:10-1:00		Lunch
1:00-2:00		Advances in PCI Harry R. Phillips, MD
2:00-3:00		Management of Acute Coronary Syndrome Harry R. Phillips, MD
3:00-3:10		Closing Remarks Jose R. Soler, MD

Faculty:
Alexandre Ferreira, MD
Associate Professor of Clinical Medicine
at the University of Miami
Medical Director of Coronary Care Unit
at Jackson Memorial Hospital
Co-director of the Interventional Cardiology
Training Program

Stuart David Katz, MD
Associate Professor of Medicine
Yale University School of Medicine
Director Yale Heart Failure and
Heart Transplantation Program

Michael A. Mathier, MD, FACC
Assistant Professor of Medicine,
University of Pittsburgh School of Medicine
Director, Pulmonary Hypertension Program

Harry R. Phillips, MD
Professor of Medicine
Duke University Medical Center
Durham, NC

Program Planning Committee:
Jose R. Soler, MD and Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 5.0 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 5 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 6 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Actelion, Amgen, Bristol-Myers Squibb, Cordis, sanofi-aventis, Schering-Plough.